Search results for "Replica"

showing 10 items of 576 documents

Mutations in hepatitis C virus RNAs conferring cell culture adaptation.

2001

ABSTRACT As an initial approach to studying the molecular replication mechanisms of hepatitis C virus (HCV), a major causative agent of acute and chronic liver disease, we have recently developed selectable self-replicating RNAs. These replicons lacked the region encoding the structural proteins and instead carried the gene encoding the neomycin phosphotransferase. Although the replication levels of these RNAs within selected cells were high, the number of G418-resistant colonies was reproducibly low. In a search for the reason, we performed a detailed analysis of replicating HCV RNAs and identified several adaptive mutations enhancing the efficiency of colony formation by several orders of…

Hepatitis C virusImmunologyReplicationHepacivirusBiologyViral Nonstructural Proteinsmedicine.disease_causeMicrobiologychemistry.chemical_compoundVirologymedicineTumor Cells CulturedHumansRepliconAmino AcidsNS5BGene3' Untranslated RegionsGeneticsMutationThree prime untranslated regionRNAVirologyAdaptation PhysiologicalchemistryCell cultureInsect ScienceMutationRNA ViralRepliconJournal of virology
researchProduct

Mutual antagonism between clock protein Period2 and hepatitis C virus replication in hepatocytes.

2013

Background: Hepatitis C virus (HCV) infects approximately 3% of the world population and is the leading cause of liver disease, impacting hepatocyte metabolism, depending on virus genotype. Hepatic metabolic functions show rhythmic fluctuations with 24-h periodicity (circadian), driven by molecular clockworks ticking through translational-transcriptional feedback loops, operated by a set of genes, called clock genes, encoding circadian proteins. Disruption of biologic clocks is implicated in a variety of disorders including fatty liver disease, obesity and diabetes. The relation between HCV replication and the circadian clock is unknown. Methods: We investigated the relationship between HCV…

Hepatitis C circadian clock viral replication interferon signaling.
researchProduct

Novel artemisinin derivatives with potential usefulness against liver/colon cancer and viral hepatitis.

2013

Antitumor and antiviral properties of the antimalaria drug artemisinin from Artemisia annua have been reported. Novel artemisinin derivatives (AD1-AD8) have been synthesized and evaluated using in vitro models of liver/colon cancer and viral hepatitis B and C. Cell viability assays after treating human cell lines from hepatoblastoma (HepG2), hepatocarcinoma (SK-HEP-1), and colon adenocarcinoma (LS174T) with AD1-AD8 for a short (6h) and long (72h) period revealed that AD5 combined low acute toxicity together with high antiproliferative effect (IC50=1-5μM). Since iron-mediated activation of peroxide bond is involved in artemisinin antimalarial activity, the effect of iron(II)-glycine sulfate …

Hepatitis Viral HumanCell SurvivalvirusesHepatitis C virusClinical BiochemistryArtemisia annuaPharmaceutical SciencePharmacologymedicine.disease_causeVirus ReplicationBiochemistrychemistry.chemical_compoundCell Line TumorDrug DiscoverymedicineAnimalsHumansArtemisininMolecular BiologyCell ProliferationHepatitis B virusHepatitisbiologyMolecular StructureChemistryOrganic ChemistryLiver Neoplasmsbiology.organism_classificationmedicine.diseaseVirologyArtemisininsColonic NeoplasmsMolecular MedicineLiver cancerViral hepatitisHeminmedicine.drugBioorganicmedicinal chemistry
researchProduct

Interferon-γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs

2002

Persistent infection with hepatitis C virus (HCV) is a major cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. All treatments known so far rely on the antiviral activity of interferon alfa (IFN-alpha) that is given alone or in combination with ribavirin. Unfortunately, only a fraction of the patients clear the virus during therapy and for those who do not respond there is currently no alternative treatment. Selectable subgenomic HCV RNAs (replicons) have been recently used to investigate the effect of IFN-alpha on HCV replication. However, it has not yet been analyzed whether other cytokines also play a role in the innate immune response against HCV. Here we show th…

HepatologyHepatitis C virusvirus diseasesBiologymedicine.disease_causeVirologydigestive system diseasesVirusNS2-3 proteaseCell killingViral replicationmedicineInterferon gammaInterferon alfamedicine.drugSubgenomic mRNAHepatology
researchProduct

Optical properties of the low-molecular amorphous azochromophores and their application in holography

2015

The films based on the low-molecular amorphous azochromophore 2-(3-(4-((4- (Ethyl(2-(trityloxy)ethyl)amino)phenyl)diazenyl)styryl)-5,5-dimethylcyclohex-2-enylidene) malononitrile (IWK-2M) were prepared. The optical properties of the material, such as transmittance and reflection spectra of the film, sensitivity to polarization holographic recording by two wavelengths (405 and 532 nm) were studied. The direct relief formation during the polarization holographic recording was explored, relief depth dependence on exposure and record beam intensity was investigated. The holographic matrix on this material base was produced without chemical etching process; the replication of holographic image w…

HistoryMaterials sciencebusiness.industryHolographyReplication (microscopy)Polarization (waves)Isotropic etchingComputer Science ApplicationsEducationAmorphous solidlaw.inventionWavelengthReflection (mathematics)lawTransmittanceOptoelectronicsbusinessJournal of Physics: Conference Series
researchProduct

Structure-Based Design of an RNA-Bindingp-Terphenylene Scaffold that Inhibits HIV-1 Rev Protein Function

2013

Hiv 1 revScaffoldAnti-HIV AgentsStereochemistryHuman immunodeficiency virus (HIV)Virus Replicationmedicine.disease_causeCatalysisStructure-Activity RelationshipTerphenyl CompoundsmedicineHumansProtein functionBinding SitesDose-Response Relationship DrugMolecular StructureChemistryRNArev Gene Products Human Immunodeficiency VirusGeneral MedicineGeneral ChemistrySmall moleculeDrug DesignHIV-1RNAStructure basedAngewandte Chemie International Edition
researchProduct

ID: 37

2015

During the early phase of human cytomegalovirus (HCMV) infection, the Interferon- γ -Inducible factor 16 (IFI16) behaves as a pattern recognition receptor (PRR) sensing viral DNA and triggering antiviral cytokine release. Later on, it restricts virus replication by down-regulating expression of viral genes committed to DNA synthesis including UL54 and UL44. These activities are modulated by viral proteins including pUL83, a tegument protein involved in viral evasion. Here, we demonstrate that pUL83 interacts with IFI16 relieving its inhibitory activity on UL54 gene transcription. We also establish that, starting from 48 h post-infection, IFI16 is stabilized and protected from degradation by…

Human cytomegalovirusDNA synthesisIFI16virusesImmunologyMutantHematologyBiologymedicine.diseaseBiochemistryMolecular biologyViral replicationInterferonGene expressionmedicineProteasome inhibitorImmunology and AllergyMolecular Biologymedicine.drugCytokine
researchProduct

The Complex Regulatory Role of Cytomegalovirus Nuclear Egress Protein pUL50 in the Production of Infectious Virus

2021

The regulation of the nucleocytoplasmic release of herpesviral capsids is defined by the process of nuclear egress. Due to their large size, nuclear capsids are unable to traverse via nuclear pores, so that herpesviruses evolved to develop a vesicular transport pathway mediating their transition through both leaflets of the nuclear membrane. This process involves regulatory proteins, which support the local distortion of the nuclear envelope. For human cytomegalovirus (HCMV), the nuclear egress complex (NEC) is determined by the pUL50-pUL53 core that initiates multicomponent assembly with NEC-associated proteins and capsids. Hereby, pUL50 serves as a multi-interacting determinant that recru…

Human cytomegalovirusGene Expression Regulation ViralProteomicsefficiency of infectious virus productionQH301-705.5Nuclear Envelope[SDV]Life Sciences [q-bio]virusesQuantitative proteomicsCytomegalovirusconditional expressionGenome Viralnuclear egress complex (NEC)Virus ReplicationArticleCell LineViral ProteinsCapsidNEC protein pUL50DNA PackagingmedicineHumansddc:610Biology (General)Nuclear poreNuclear membraneregulation of viral replicationGenes Immediate-EarlyCell Nucleusfunctional propertiesChemistryVirionGeneral MedicineFibroblastsmedicine.diseaseCell biologyVesicular transport protein[SDV] Life Sciences [q-bio]Kineticsmedicine.anatomical_structureLytic cycleCapsidhuman cytomegalovirusLamin
researchProduct

In Vivo Replication of Recombinant Murine Cytomegalovirus Driven by the Paralogous Major Immediate-Early Promoter-Enhancer of Human Cytomegalovirus

1999

ABSTRACT Transcription of the major immediate-early (MIE) genes of cytomegaloviruses (CMV) is driven by a strong promoter-enhancer (MIEPE) complex. Transactivator proteins encoded by these MIE genes are essential for productive infection. Accordingly, the MIEPE is a crucial control point, and its regulation by activators and repressors is pertinent to virus replication. Since the MIEPE contains multiple regulatory elements, it was reasonable to assume that specific sequence motifs are irreplaceable for specifying the cell-type tropism and replication pattern. Recent work on murine CMV infectivity (A. Angulo, M. Messerle, U. H. Koszinowski, and P. Ghazal, J. Virol. 72:8502–8509, 1998) has do…

Human cytomegalovirusImmunologyReplicationCytomegalovirusBiologyVirus ReplicationRecombinant virusMicrobiologyMiceVirologymedicineAnimalsPromoter Regions GeneticEnhancerGenes Immediate-EarlyGeneIn Situ HybridizationTropismRecombination GeneticInfectivityMice Inbred BALB CPromotermedicine.diseaseVirologyEnhancer Elements GeneticLiverViral replicationInsect ScienceFemaleJournal of Virology
researchProduct

Modification of the major tegument protein pp65 of human cytomegalovirus inhibits virus growth and leads to the enhancement of a protein complex with…

2010

The tegument protein pp65 of human cytomegalovirus (HCMV) is abundant in lytically infected human foreskin fibroblasts (HFF), as well as in virions and subviral dense bodies (DB). Despite this, we showed previously that pp65 is dispensable for growth in HFF. In the process of refining a DB-based vaccine candidate, different HCMV mutants were generated, expressing a dominant HLA-A2-presented peptide of the IE1 protein fused to pp65. One of the mutant viruses (RV-VM1) surprisingly showed marked impairment in virus release from HFF. We hypothesized that analysis of the phenotypic alterations of RV-VM1 would provide insight into the functions of pp65, poorly defined thus far. RV-VM1 infection r…

Human cytomegalovirusImmunoprecipitationvirusesMutantCytomegalovirusBiologyVirus ReplicationVirusInclusion bodiesViral Matrix ProteinsViral ProteinsVirologymedicineHumansImmunoprecipitationCells Culturedvirus diseasesRNAViral tegumentFibroblastsPhosphoproteinsmedicine.diseaseVirologyFusion proteinTrans-ActivatorsProtein MultimerizationProtein BindingJournal of General Virology
researchProduct